When Dr. Carl June first heard about symptoms in seriously ill COVID-19 patients, his thoughts jumped to Emily Whitehead. Seven-year-old Emily had endured the same kind of immune over-reaction when June treated her in 2012 with an experimental therapy against her leukemia.
Her immune system went into life-threatening overdrive, just like many of those with COVID-19.
In a last-ditch effort to save Emily's life, he had given her a drug, tocilizumab, that kept his own daughter's rheumatoid arthritis under control. To everyone's surprise, the drug worked. Emily is now a normal teenager.
Tocilizumab is now one of hundreds of therapies being tested against COVID-19.
Four months ago when COVID-19 first arrived in the United States, there were no therapies shown to treat it. Doctors relied solely on what's called supportive care including intravenous fluids, fever reducers, and ventilators, those bulky machines that allow people to breathe when they can't do it anymore on their own.
Today, there are two approved therapies shown to make a difference in COVID-19, and 150 treatments and more than 50 antivirals are being tested in people.
A treatment that kept people from falling seriously ill or even needing hospitalization at all could strip the fear from the coronavirus and allow people to resume their pre-COVID-19 lives.
Once somebody develops a treatment for the virus, everything will go away, said Daniel Batlle, a kidney expert from Northwestern Medicine and professor of medicine at Northwestern University in Chicago.
Even after a vaccine is developed, treatments that save lives and prevent hospitalization will be crucial. Vaccines might not work for everyone and doses may initially be limited.
Treatments under development
The vast majority of people diagnosed with COVID-19 more than 80% will recover without the need for hospitalization or significant treatment.
For those who do require care, treatments have been evolving as researchers learn more about the coronavirus and the infection it causes, as well as the havoc it can wreak on various parts of the body.
Potential therapies being tested, experts said, fall into four major categories that are best used at different times:
Antivirals that slow or block the virus expansion in the body will be most effective early in infection, before the virus is fully established;
Convalescent plasma and antibodies that provide immune weapons to attack the virus once its established could help control infections and avoid the need for hospitalization;
Immune system modulators, most that tamp down an over-reacting immune system, will be particularly useful later in the course of disease, when the immune response rather than the virus is driving the patients condition;
Anti-coagulants that stop or slow the blood clots that can cause organ damage or stroke are also likely to be most useful in patients having a serious reaction to the virus.
But even as these different approaches are being tested, many unanswered questions and challenges remain. One is how to treat patients who might have different responses to the virus, said Dr. John Wherry, director of the institute for immunology at the Perlman School of Medicine at the University of Pennsylvania.
At Penn, he and his colleagues have seen three types of patients: a large group whose immune system is over-reacting, a small group whose immune system is under-reacting, and others where the immune system is more balanced in the response.
Right now, drugs are tested on all patients without making any distinction, Wherry said. That means ones that tamp down the immune system might help patients with an over-active immune system but hurt those whose immune systems arent working hard enough, and do nothing for those with a balanced immune response.
And drugs that might be useful for patients with too little immune response might be seen as ineffective because they don't help the larger number of people with immune overreactions, he said.
Wherry said researchers are getting closer to being able to identify which patients are likely to do better with which kind of therapy. We still need to be pushing very hard and thinking very creatively about how to match treatments to the right patient, he said.
Doctors are learning other approaches simply by treating patients.
Batlle, the kidney expert, said although COVID-19 has been considered a lung disease, as many as half of patients hospitalized with severe cases also suffer acute kidney injury. Its not yet clear how many patients will be left with long-term kidney problems after recovering from severe cases of COVID-19.
We dont want to scare anybody, but kidney damage was initially under-reported, and now several studies have shown that it is extremely frequent in hospitalized patients," he said.
Treatment for acute kidney injury usually involves dialysis, which removes toxins from the blood that the kidneys can no longer address. But Batlle is hopeful treatments that address COVID-19-related inflammation and formation of blood clots will eventually reduce such injuries.
We should be better prepared to help these patients and not rely (only) on supportive care, he said.
Just two drugs recommended so far
Since mid-May, dexamethasone and remdesivir have been shown useful for certain COVID-19 patients. Both are recommended by the National Institutes of Health and the Infectious Disease Society of America.
For hospitalized patients, these drugs are beginning to show an effect, said Dr. Rajesh Gandhi, an infectious disease specialist at Massachusetts General Hospital who sits on both panels.
Placing patients on their stomachs rather than their back when they have breathing problems may also help, according to some experts.
And Gandhi and other doctors said they are now much more comfortable treating COVID-19s many symptoms, which can include blood clots, immune problems and organ failure, in addition to lung issues.
Some now even say that COVID-19 is a multi-system disease, targeting at times the lining of blood vessels. This would explain how it manages to damage so many of the body's organs, all of which are fed by blood vessels.
One recent study, still not fully vetted, showed that dexamethasone, at a dose of 6 mg per day for up to 10 days, can be lifesaving for patients with COVID-19 who are on ventilators. The evidence was weaker for patients who are hospitalized and receiving oxygen. The study found no support for giving the steroid to less seriously ill COVID-19 patients, but more research is underway.
In a May study in the New England Journal of Medicine, the drug remdesivir, first developed to treat Ebola, was shown to shorten the recovery time of patients hospitalized with COVID-19 and lower respiratory tract infections.
Scientists think remdesivir might be even more effective in people who are not yet sick enough to require hospitalization, but because it can only be delivered intravenously at the moment, it has not been tested on outpatients. Its manufacturer, Gilead, is rushing to ramp up production and to develop an inhaled version of the drug.
But while remdesivir is helpful, it doesnt cure COVID-19 and is far from a home run, said Dr. Mark Rupp, an infectious disease expert at the University of Nebraska.
Its kind of like getting on base with a single, he said. Weve got a long way to go.
As hydroxychloroquine shows, research is key
Although its tempting to just throw everything in the medicine cabinet at COVID-19, Rupp said he learned while fighting Ebola in 2014-2015 that its much more important to conduct high-quality clinical research during an outbreak.
Without such research, you throw the kitchen sink at everybody and you dont know what helps and what hurts and thats a dangerous place to be, he said.
He cited the example of hydroxychloroquine, which was used early on to treat COVID-19, but which research has shown to be ineffective in very sick patients.
Everybody wants to do good, we want to help our patients, Rupp said. But sometimes well-meaning efforts really dont result in beneficial effects.
Its only by testing drugs and other therapies through clinical trials that doctors can learn what works and what doesnt, he added. The more data and information we can gather, the better off were going to be.
Health and patient safety coverage at USA TODAY is made possible in part by a grant from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare. The Masimo Foundation does not provide editorial input.
- Technion team discovers important adaptive strategy of the microbiome, impacting immune system - The Jerusalem Post - April 16th, 2024
- Targeting aging and age-related diseases with vaccines - Nature.com - April 16th, 2024
- Single cell analysis unveils B cell-dominated immune subtypes in HNSCC for enhanced prognostic and therapeutic ... - Nature.com - April 16th, 2024
- After the Smoke Clears: Scars on the Immune System - The Scientist - April 16th, 2024
- Exercise and the Immune System: What's the Latest Research? - Technology Networks - April 16th, 2024
- Analysis of immune cell infiltration characteristics in severe acute pancreatitis through integrated bioinformatics ... - Nature.com - April 16th, 2024
- Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original ... - Nature.com - April 16th, 2024
- Harnessing the power of the body's own cells to defeat cancer - Press Publications Inc. - April 16th, 2024
- Best Life: Immunotherapy targets brain cancer - Action News 5 - April 16th, 2024
- Dietary factors and their influence on immunotherapy strategies in oncology: a comprehensive review | Cell Death ... - Nature.com - April 16th, 2024
- New insights on B cells: Researchers explore building better antibodies and curbing autoimmune diseases - Medical Xpress - April 16th, 2024
- Immune cells' intense reaction to the coronavirus may lead to pneumonia - Science News Magazine - April 16th, 2024
- The telltale traces long Covid leaves in the blood - healthcare-in-europe.com - April 16th, 2024
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- SUNDAY Unraveling The Gut-Brain Connection: How Infant Gut Bacteria Shape Immune Resilience | TheHealthSit - TheHealthSite - March 18th, 2024
- Making drugs from T cells: The quantitative pharmacology of engineered T cell therapeutics | npj Systems Biology and ... - Nature.com - March 18th, 2024
- Study unlocks the mystery of neonatal neutropenia in newborns - News-Medical.Net - March 18th, 2024
- Vertebral Subluxation and Systems Biology: An Integrative Review Exploring the Salutogenic Influence of Chiropractic ... - Cureus - March 18th, 2024
- A new strategy to attack aggressive brain cancer shrank tumors in two early tests - ABC News - March 18th, 2024
- Turning on the Bat Signal - The Scientist - March 18th, 2024
- Power Foods That Can Support Your Immune System - Videos from The Weather Channel - The Weather Channel - March 18th, 2024
- Report: Aggressive brain tumors respond to new, immune-focused therapy - UPI News - March 18th, 2024
- Designer immune-cell therapy could shrink deadly brain tumors, early trials show - Livescience.com - March 18th, 2024
- 20.2: Introduction to the Immune System - Biology LibreTexts - February 27th, 2024
- Can one shot of yoghurt really boost your immunity and gut health? - Daily Mail - February 27th, 2024
- New cancer therapy approved by FDA supercharges bodys immune system - The Washington Post - February 27th, 2024
- How bubonic plague rewired the human immune system - BBC.com - February 27th, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Participate in Our Study for $100; Open Slots This Week - University of Arkansas Newswire - February 27th, 2024
- Sexual dimorphism during integrative endocrine and immune responses to ionizing radiation in mice | Scientific Reports - Nature.com - February 27th, 2024
- Comprehensive pan-cancer analysis identifies the RNA-binding protein LRPPRC as a novel prognostic and immune ... - ScienceDirect.com - February 27th, 2024
- YOUR HEALTH: The HAMR fights cancer - WAFB - February 27th, 2024
- Cycles of a diet that mimics fasting can reduce signs of immune system aging, as well as insulin resistance and liver fat - News-Medical.Net - February 27th, 2024
- How the powerhouse of the cell could be cancers Achilles heel - Freethink - February 27th, 2024
- Food is medicine: The science behind zinc and other supplements for immune health - Healio - February 27th, 2024
- Unleashing Our Immune Response to Quash Cancer - Medscape - February 27th, 2024
- Tumor histoculture captures the dynamic interactions between tumor and immune components in response to anti-PD1 ... - Nature.com - February 27th, 2024
- Converging and evolving immuno-genomic routes toward immune escape in breast cancer - Nature.com - February 27th, 2024
- Sanjula Jain Urges a Comprehensive Approach in Address Alarming Rise in Cancer Cases Among Younger Populations - Managed Healthcare Executive - February 27th, 2024
- Cystic fibrosis breakthrough points to zinc as infection buster - New Atlas - February 27th, 2024
- Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIVworkshop ... - Nature.com - February 27th, 2024
- Is the 100-year old TB vaccine a new weapon against Alzheimers? - The Guardian - February 27th, 2024
- Immune system in the blood of Alzheimer's patients found to be epigenetically altered - News-Medical.Net - February 10th, 2024
- What impact does exercise have on your immune system? And how to stay well while cycling - BikeRadar - February 10th, 2024
- Had COVID recently? Here's what to know about how long immunity lasts, long COVID, and more - AAMC - February 10th, 2024
- Noor Momin harnesses the immune system to treat heart disease | Penn Today - Penn Today - February 10th, 2024
- Research reveals a process tumors use to induce immune suppressor cells and evade immunotherapy - Medical Xpress - February 10th, 2024
- Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure - Nature.com - February 10th, 2024
- Preventing severe allergic reactions with nanoparticles - National Institutes of Health (NIH) (.gov) - February 10th, 2024
- Sugary handshakes are how cells talk to each other understanding these name tags can clarify how the immune ... - The Conversation Indonesia - February 10th, 2024
- Scientists have identified an immune cell that can cause allergies - EL PAS USA - February 10th, 2024
- Sickle cell and the importance of the immune system - Punch Newspapers - February 10th, 2024
- Which cancers can be treated with immune checkpoint inhibitors? - MD Anderson Cancer Center - February 10th, 2024
- How does waste leave the brain? Washington University School of Medicine in St. Louis - Washington University School of Medicine in St. Louis - February 10th, 2024
- Healthy Kids: Give your immune system a boost to stay healthy this winter - nbc16.com - February 10th, 2024
- The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode ... - Cardiovascular Diabetology - February 10th, 2024
- Impact of Chronic Stress on Immune System and Depression | Health News - Medriva - February 10th, 2024
- I tried 'swamp soup,' the viral recipe that promises to boost your immune system - Yahoo News - February 10th, 2024
- Understanding Immune Checkpoint Inhibition Therapy: Challenges and Strategies - Medriva - February 10th, 2024
- One Simple Change May Dramatically Boost The Effect of COVID-19 Vaccines - ScienceAlert - February 10th, 2024
- The gut virome is associated with stress-induced changes in behaviour and immune responses in mice - Nature.com - February 10th, 2024
- Cancer vaccines are in the works to fight BRCA-linked gene mutations - The Philadelphia Inquirer - February 10th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Novel insights into the immune response to bacterial T cell superantigens - Nature.com - January 17th, 2024
- FDA signs off on Takeda's HyQvia as maintenance therapy for CIDP - FiercePharma - January 17th, 2024
- CBDs Pobezinsky and Pobezinskaya Use Flow Cytometry to Determine How Tumor Cells Outwit the Bodys Immune ... - UMass News and Media Relations - January 17th, 2024
- Boosting. What To Do. - Science Based Medicine - January 17th, 2024
- Axelia Oncology takes its TLR2/6 agonist into the clinic to harness the innate immune system - BioWorld Online - January 17th, 2024
- Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to ... - Nature.com - January 17th, 2024
- Opinion | Thanks to mRNA, Future Drugs Will Be Easier and Faster to Make - Mississippi Free Press - January 17th, 2024
- Elon research team models the COVID immune response, one equation at a time - Today at Elon - January 17th, 2024
- Are plant-based meals good for your immune system? 4 things to know about improving your health this week. - Yahoo Life - January 17th, 2024
- Scientists Find Key To Potential Breast Cancer Prevention, Treatment | Newsroom - UNC Health and UNC School of Medicine - January 17th, 2024
- What if every germ hit you at the exact same time? An immunologist explains - The Conversation - January 17th, 2024
- Why Don't We Have a Staph Vaccine? - Healthnews.com - January 17th, 2024
- Best ways to improve your immune system - The Business Standard - January 17th, 2024
- Stanford University researchers think future pandemics could be prevented with universal vaccines - KGO-TV - January 17th, 2024
- Why you may feel depressed and anxious when you're ill and how to cope with it - The Conversation - January 17th, 2024
- New mechanism with potential to boost checkpoint-blocking cancer immunotherapies identified - Medical Xpress - January 17th, 2024
- Battling Bugs and Blues: The Interplay of Infection and Emotion - News-Medical.Net - January 17th, 2024